Graffiti

FDA 510(k) K202189 · Ge Medical Systems Information Technologies, Inc.

Substantially Equivalent

510(k) numberK202189

Submission

Device name
Graffiti
Applicant
Ge Medical Systems Information Technologies, Inc.
Wauwatosa, WI, US
Received
August 4, 2020
Decision date
December 8, 2020
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DQK – Computer, Diagnostic, Programmable
Device class
Class II (moderate risk)
Regulation
21 CFR 870.1425
Specialty
Cardiovascular

Other 510(k)s with product code DQK

510(k)DeviceApplicantDecision
K262005Affera Integrated Mapping SystemDQK · Special Medtronic, Inc.08/21/2026SE
K253692AVVIGO™+ Multi-Modality Guidance SystemDQK · Traditional Boston Scientific08/21/2026SE
K253576CorVista System® with PCWP Add-OnDQK · Traditional Analytics For Life, Inc.07/26/2026SE
K262006EnSite™ X EP SystemDQK · Special Abbott Medical07/15/2026SE
K252978ScioCardio ECG Analysis PlatformDQK · Traditional Synergen Technology Labs, LLC07/09/2026SE
K253463ILR ECG Analyzer (IM007)DQK · Traditional Implicity, Inc.07/02/2026SE
K261119NorthStar Mapping System (MAP01 or MAP01-01)DQK · Special Imricor Medical Systems, Inc.06/30/2026SE
K253088OneStim-DUO Cardiac Stimulator (MP5003-4CO)DQK · Traditional Micropace Pty, Ltd.06/12/2026SE
K261329Intra-Operative Positioning System (IOPS) (MC-1);IOPS Viewpoint Simple Curve Catheter…DQK · Special Centerline Biomedical06/10/2026SE
K252859ZEUS Platform (FG0501US)DQK · Traditional iRhythm Technologies, Inc.05/29/2026SE

More from iRhythm Technologies, Inc.

510(k)DeviceDecision
K253277Monitor B105M; Monitor B125M; Monitor B155M; Monitor B105P; Monitor B125PMHX · Traditional 07/24/2026SE
K251670MAC 7 Resting ECG Analysis SystemDPS · Traditional 01/26/2026SE
K242562Monitor B105M; Monitor B125M; Monitor B155M; Monitor B105P; Monitor B125PMHX · Traditional 07/09/2025SE
K243540Mac-Lab (AltiX AI.i); CardioLab (AltiX AI.i); ComboLab (AltiX AI.i); MLCL Client…DQK · Special 12/12/2024SE
K233810Portrait VSMMWI · Traditional 04/25/2024SE
K234130Portrait™ Mobile Monitoring Solution consists of: • Portrait™ Central Viewer Application…MWI · Traditional 03/20/2024SE
K231870CASE V7.0 Cardiac Testing System and CardioSoft V7.0 Cardiac Testing SystemDQK · Traditional 12/13/2023SE
K230626Portrait™ Central Viewer Application (Portrait CV A01), Portrait ™ Core Services…MWI · Traditional 08/11/2023SE
K230145One-CufDXQ · Traditional 03/14/2023SE
K222586Mural Clinical ViewerMHX · Traditional 12/21/2022SE

Questions and answers

When was Graffiti cleared by the FDA?

Graffiti (K202189) received a 510(k) decision of Substantially Equivalent on December 8, 2020, 126 days after the submission was received.

What is the product code of K202189?

The FDA product code is DQK – Computer, Diagnostic, Programmable, a Class II (moderate risk) device regulated under 21 CFR 870.1425.